$MDLN Balance Sheet | Understand Stock

$MDLN

$32.38 -$1.31 (3.89%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 27, 2026	Q1 FY2026 As of Mar 28, 2026	Q4 FY2025 As of Dec 31, 2025
ASSETS
Current assets
Cash and cash equivalents
Trade accounts receivable, net of allowance for credit losses of $148 and $152 as of June 27, 2026 and December 31, 2025, respectively
Inventories
Short-term investments
Other current assets
Total current assets
Property, plant, and equipment, net
Other non-current assets
Goodwill
Intangible assets, net
Deferred tax assets
Other long-term assets
Total other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Current portion of long-term borrowings and other short-term borrowings
Accounts payable
Accrued expenses and other current liabilities
Total current liabilities
Non-current liabilities
Long-term borrowings, less current portion
Tax receivable agreement liability
Other long-term liabilities
Total non-current liabilities
Total liabilities
Mezzanine equity
Stockholders’ equity
Common stock
Preferred stock
Additional paid-in capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive (loss) income
Total Medline Inc. stockholders’ equity
Noncontrolling interests
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments